Table 1.
Pathogenesis Stage | Copy Number Alterations | Associated Gene | Associated Protein [21] | Signal Pathway (If Known) |
Biologic Activity and Function (If Known) |
---|---|---|---|---|---|
Adenoma to Carcinoma | Gain of 8q [22] | c-MYC | c-MYC | Transcription factor that facilitates cell proliferation and survival | |
Gain of 20q [23,24,25,26] | ADRM1 | Adrm1 | Component of 26S proteasome that encodes a cell adhesion molecule | ||
AURKA | Aurora Kinase A | Wnt and Ras-MAPK | Serine threonine kinase that induces centrosome amplification and aneuploidy | ||
BCL2L1 | Bcl-2-like protein 1 | Caspase activation inhibitor that regulates apoptosis | |||
C20orf20 | MRG/MORF4L-binding protein | Histone acetylation that binds to MRG15/MRGX proteins and is associated with cancer cell growth | |||
C20orf24 | Respirasome Complex Assembly Factor 1 | Mitochondrial respirasome assembly | |||
SRC | Src | STAT3, PI3K, RAS | Non-receptor protein kinase that promotes tumor progression and metastasis | ||
TCFL5 | Transcription factor-like 5 protein | Transcription factor | |||
TH1L | Negative elongation factor C/D | MEK/ERK | Helps regulate A-raf kinase, which is involved in MEK/ERK pathway activation | ||
Loss of 8p [27,28,29] | DLC1 | Rho GTPase-activating protein 7 | MAPK | GTPase-activating protein involved in fatty acid and ceramide metabolism | |
Loss of 17p [22] | p53 | p53 | p53 | Tumor suppressor, transcription factor | |
Loss of 18q21 [6,30] | DCC | DCC | Nectrin-1 receptor that facilitates apoptosis |
||
SMAD4 | SMAD4 | TGF-β | Transcription factor and tumor suppressor that regulates TGF-β pathway | ||
Disease Progression | Loss of 3p14.2 [31] | FHIT | Bis(5’-adenosyl)-triphosphatase | PI3K/AKT | Dinucleoside triphosphate hydrolase that regulates apoptosis |
Loss of 4p [32] | |||||
Deletion of 5p15.1 [33,34] | FAM134B | Reticulophagy regulator 1 |
AKT | Autophagy receptor and tumor suppressor |
|
Distant Metastasis | Gain of 1q [32] | ||||
Amplification of 3q26 [35] | PIK3CA | PIK3CA | PI3K/AKT | Kinase involved in PI3K/AKT signaling pathway | |
Amplification of 8p11.23 [36] | FGFR1 | FGFR1 | MAPK, PI3K/AKT | Receptor tyrosine kinase for fibroblast growth factors | |
Gain of 8q [37,38] | PRL-3 | PRL-3 | NF-kB | Protein tyrosine phosphatase that facilitates glycolysis, glucose metabolism, and lactate production | |
Amplification of 11q [39] | |||||
Amplification of 12p13.33 [32] | WNK1 | WNK1 | WNK | Serine/threonine protein kinase that facilitates cell cycle progression | |
Amplification of 13q12 [35,40] | CDK8 | CDK8 | mTOR | Protein phosphorylator that regulates β-catenin activity | |
Amplification of 17q12 [35] | ERBB2 | ERBB2 | PI3K/AKT | Receptor tyrosine kinase that leads to cellular growth |
|
Gain of 19 [32] | |||||
Loss of 1p35 [41] | S100PBP | S100PBP | Interacts with S100 calcium-binding protein P | ||
CSMD2 | CSMD2 | Tumor suppressor involved in complement cascade |
|||
Loss of 5q31 [41] | TGFBI | TGFBI | PI3K/AKT | Precursor of TGFBI and inhibits tumor cell invasion | |
Loss of 8p21 [42,43] | TNFRSF10C | TNFRSF10C | Receptor for the cytotoxic ligand TRAIL and inhibits apoptosis |
||
Loss of 14p [32] | |||||
Deletion of 17p [44,45,46] | p53 | p53 | p53 | Tumor suppressor | |
Deletion of 22q11.2 [46] |